Company Filing History:
Years Active: 2004-2010
Title: The Innovative Contributions of Donald E. Awrey
Introduction
Donald E. Awrey is a notable inventor based in Mississauga, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of novel drug targets for pathogenic bacteria. With a total of three patents to his name, Awrey's work has the potential to impact the medical community significantly.
Latest Patents
Awrey's latest patents focus on innovative drug targets for pathogenic bacteria. One of his inventions provides a purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. This invention also details the biochemical and biophysical characteristics of the polypeptides involved. Another patent similarly relates to drug targets, offering a purified protein derived from the amino acid sequence set forth in SEQ ID NO: 2, along with its biochemical and biophysical characteristics.
Career Highlights
Donald E. Awrey is currently associated with Affinium Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work at Affinium Pharmaceuticals has positioned him as a key player in the biotechnology sector.
Collaborations
Awrey has collaborated with notable colleagues, including Judd Berman and Molly B. Schmid. These partnerships have likely contributed to the innovative nature of his work and the successful development of his patents.
Conclusion
In summary, Donald E. Awrey is a distinguished inventor whose work in biotechnology has led to significant advancements in drug development. His contributions are poised to make a lasting impact on the medical field.